Where Will Bicycle Therapeutics PLC (BCYC) Stock Go Next After It Is Down 0.72% in a Week?

Bicycle Therapeutics PLC (BCYC) stock has fallen 0.72% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Bicycle Therapeutics PLC has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BCYC!

See Full BCYC Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With BCYC Stock Today?

Bicycle Therapeutics PLC (BCYC) stock is trading at $24.91 as of 11:23 AM on Thursday, Mar 7, a rise of $0.27, or 1.08% from the previous closing price of $24.64. The stock has traded between $24.58 and $25.22 so far today. Volume today is light. So far 95,896 shares have traded compared to average volume of 385,273 shares. To screen for more stocks like Bicycle Therapeutics PLC click here.

More About Bicycle Therapeutics PLC

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Click Here to get the full Stock Report for Bicycle Therapeutics PLC stock.